CNTB
Connect Biopharma Holdings LimitedNASDAQHealthcare$2.99+9.93%ClosedMarket Cap: $167.2M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
3.96
P/S
0.00
EV/EBITDA
-2.23
DCF Value
$0.64
FCF Yield
-30.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-97.9%
ROA
-99.0%
ROIC
-135.7%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $-48.0K | 100.0% | $-44.6M | $-42.6M | $-0.77 | — |
| FY 2025 | $0.00 | NaN% | $-58.1M | $-55.5M | $-1.00 | — |
| Q2 2025 | $48.0K | 100.0% | $-13.4M | $-12.9M | $-0.23 | — |
| Q4 2024 | $1.9M | 90.4% | $-24.9M | $-23.2M | $-0.42 | — |
| FY 2024 | $26.0M | 100.0% | $-22.5M | $-15.6M | $-0.28 | — |
| Q2 2024 | $24.1M | 98.0% | $7.3M | $7.6M | $0.14 | — |
| Q4 2023 | $0.00 | -Infinity% | $-27.2M | $-28.9M | $-0.52 | — |
| FY 2023 | $0.00 | -Infinity% | $-62.1M | $-59.5M | $-1.08 | — |
| Q2 2023 | $0.00 | -Infinity% | $-34.8M | $-30.6M | $-0.56 | — |
| Q4 2022 | $0.00 | -Infinity% | $-54.3M | $-56.7M | $-1.03 | — |
| FY 2022 | $0.00 | -Infinity% | $-117.7M | $-116.4M | $-14.50 | — |
| Q2 2022 | $0.00 | -Infinity% | $-63.4M | $-59.7M | $-13.47 | — |